XML 48 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Note Receivable (Details) - USD ($)
 1 Months Ended 12 Months Ended
Apr. 04, 2022
Dec. 10, 2021
Dec. 28, 2021
Oct. 18, 2021
Aug. 25, 2021
Dec. 31, 2021
Dec. 31, 2022
Jan. 31, 2022
Nov. 30, 2021
Aug. 27, 2021
Mar. 31, 2021
Jan. 31, 2021
Oct. 31, 2020
Receivables [Abstract]                          
Completion of a proposed         $ 6,500,000                
Common stock yields percentage         50.00%                
Share exchange agreement, description     On December 28, 2021, we entered into a Share Exchange Agreement with Cellvera Global f/k/a AiPharma Global, pursuant to which we (i) will acquire 9.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 96,324 shares of our common stock of Aditxt and a cash payment of $250,000, at an initial closing upon the satisfaction or waiver of certain conditions to closing; and (ii) acquire the remaining 90.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 798,560 shares of our common stock and a cash payment of $250,000 at a secondary closing upon the satisfaction or waiver of certain conditions to closing.                    
Principal amount                   $ 6,500,000      
Interest rate per annum                 8.00%   8.00% 8.00% 8.00%
Credit agreement amendment, description       the Company entered into the first amendment to the Credit Agreement with Cellvera Global and certain affiliated entities (the “Credit Agreement Amendment”), pursuant to which the Company agreed to increase the amount which Cellvera Global was permitted to borrow under the Credit Agreement by $8.5 million to an aggregate of $15.0 million, of which $6.5 million was outstanding prior to entering the Credit Agreement Amendment. The Company agreed to fund such additional borrowings, as requested by Cellvera Global, by advancing 70% of any amounts received by the Company from the exercise of existing warrants or any other capital raises, including the October Offering.                  
Advanced credit agreement           $ 8,000,000              
Credit agreement           14,500,000              
Note receivable amount           $ 14,500,000              
Credit agreement               $ 14,500,000          
Aggregate amount $ 30,000,000                        
Principal amount   $ 500,000                      
Debt loan amount   4,500,000                      
Loan interest rate   $ 8                      
Accrued interest             $ 500,000